Evidence that the bulge region is a site of relative immune privilege in human hair folliclesCitation formats

  • External authors:
  • K. C. Meyer
  • J. E. Klatte
  • H. V. Dinh
  • M. J. Harries
  • K. Reithmayer
  • W. Meyer
  • R. Sinclair

Standard

Evidence that the bulge region is a site of relative immune privilege in human hair follicles. / Meyer, K. C.; Klatte, J. E.; Dinh, H. V.; Harries, M. J.; Reithmayer, K.; Meyer, W.; Sinclair, R.; Paus, R.

In: British Journal of Dermatology, Vol. 159, No. 5, 11.2008, p. 1077-1085.

Research output: Contribution to journal › Article › peer-review

Harvard

Meyer, KC, Klatte, JE, Dinh, HV, Harries, MJ, Reithmayer, K, Meyer, W, Sinclair, R & Paus, R 2008, 'Evidence that the bulge region is a site of relative immune privilege in human hair follicles', British Journal of Dermatology, vol. 159, no. 5, pp. 1077-1085. https://doi.org/10.1111/j.1365-2133.2008.08818.x

APA

Meyer, K. C., Klatte, J. E., Dinh, H. V., Harries, M. J., Reithmayer, K., Meyer, W., Sinclair, R., & Paus, R. (2008). Evidence that the bulge region is a site of relative immune privilege in human hair follicles. British Journal of Dermatology, 159(5), 1077-1085. https://doi.org/10.1111/j.1365-2133.2008.08818.x

Vancouver

Meyer KC, Klatte JE, Dinh HV, Harries MJ, Reithmayer K, Meyer W et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. British Journal of Dermatology. 2008 Nov;159(5):1077-1085. https://doi.org/10.1111/j.1365-2133.2008.08818.x

Author

Meyer, K. C. ; Klatte, J. E. ; Dinh, H. V. ; Harries, M. J. ; Reithmayer, K. ; Meyer, W. ; Sinclair, R. ; Paus, R. / Evidence that the bulge region is a site of relative immune privilege in human hair follicles. In: British Journal of Dermatology. 2008 ; Vol. 159, No. 5. pp. 1077-1085.

Bibtex

@article{2b9c63223d7541b4992fabea91119602,
title = "Evidence that the bulge region is a site of relative immune privilege in human hair follicles",
abstract = "Background: Recent gene profiling data suggest that, besides the anagen hair bulb, the epithelial stem cell region in the outer root sheath of hair follicles (HFs), termed the bulge, may also represent an area of relative immune privilege (IP). Objectives: To investigate whether the human HF bulge is a site of relative IP within anagen VI HFs. Methods: Anagen VI HFs from normal human scalp skin were analysed using immunohistological staining techniques, quantitative histomorphometry and statistical analysis. For functional evidence we performed full-thickness human scalp skin organ cultures to investigate whether interferon (IFN)-γ, a key inducer of IP collapse in hair bulbs, has a similar effect on the putative bulge IP. Results: Major histocompatibility complex (MHC) class Ia, β2-microglobulin and MHC class II immunoreactivity are downregulated in the human bulge. The immunosuppressants α-melanocyte stimulating hormone, transforming growth factor-β2, macrophage migration inhibitory factor and indoleamine-2,3-dioxygenase (IDO) are upregulated in the CD200+, stem cell-rich bulge region. These CD200+ cells also co-express HLA-E. Furthermore, IFN-γ induces significant ectopic MHC class Ia expression in bulge cells of organ-cultured human scalp skin. Conclusions: These data suggest that the bulge of human anagen HFs represents a hitherto unrecognized site of relative IP in human skin. Simultaneously, we present the first evidence of IDO and HLA-E protein expression in normal human HFs. Bulge IP presumably protects the HF epithelial stem cell reservoir from autoaggressive immune attack whereas a loss of bulge IP may play a central role in the pathogenesis of cicatricial alopecias. {\textcopyright} 2008 The Authors.",
keywords = "Bulge, HLA-E, Human hair follicles, Immune privilege, Indoleamine-2,3- dioxygenase, Macrophage migration inhibitory factor",
author = "Meyer, {K. C.} and Klatte, {J. E.} and Dinh, {H. V.} and Harries, {M. J.} and K. Reithmayer and W. Meyer and R. Sinclair and R. Paus",
year = "2008",
month = nov,
doi = "10.1111/j.1365-2133.2008.08818.x",
language = "English",
volume = "159",
pages = "1077--1085",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "John Wiley & Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - Evidence that the bulge region is a site of relative immune privilege in human hair follicles

AU - Meyer, K. C.

AU - Klatte, J. E.

AU - Dinh, H. V.

AU - Harries, M. J.

AU - Reithmayer, K.

AU - Meyer, W.

AU - Sinclair, R.

AU - Paus, R.

PY - 2008/11

Y1 - 2008/11

N2 - Background: Recent gene profiling data suggest that, besides the anagen hair bulb, the epithelial stem cell region in the outer root sheath of hair follicles (HFs), termed the bulge, may also represent an area of relative immune privilege (IP). Objectives: To investigate whether the human HF bulge is a site of relative IP within anagen VI HFs. Methods: Anagen VI HFs from normal human scalp skin were analysed using immunohistological staining techniques, quantitative histomorphometry and statistical analysis. For functional evidence we performed full-thickness human scalp skin organ cultures to investigate whether interferon (IFN)-γ, a key inducer of IP collapse in hair bulbs, has a similar effect on the putative bulge IP. Results: Major histocompatibility complex (MHC) class Ia, β2-microglobulin and MHC class II immunoreactivity are downregulated in the human bulge. The immunosuppressants α-melanocyte stimulating hormone, transforming growth factor-β2, macrophage migration inhibitory factor and indoleamine-2,3-dioxygenase (IDO) are upregulated in the CD200+, stem cell-rich bulge region. These CD200+ cells also co-express HLA-E. Furthermore, IFN-γ induces significant ectopic MHC class Ia expression in bulge cells of organ-cultured human scalp skin. Conclusions: These data suggest that the bulge of human anagen HFs represents a hitherto unrecognized site of relative IP in human skin. Simultaneously, we present the first evidence of IDO and HLA-E protein expression in normal human HFs. Bulge IP presumably protects the HF epithelial stem cell reservoir from autoaggressive immune attack whereas a loss of bulge IP may play a central role in the pathogenesis of cicatricial alopecias. © 2008 The Authors.

AB - Background: Recent gene profiling data suggest that, besides the anagen hair bulb, the epithelial stem cell region in the outer root sheath of hair follicles (HFs), termed the bulge, may also represent an area of relative immune privilege (IP). Objectives: To investigate whether the human HF bulge is a site of relative IP within anagen VI HFs. Methods: Anagen VI HFs from normal human scalp skin were analysed using immunohistological staining techniques, quantitative histomorphometry and statistical analysis. For functional evidence we performed full-thickness human scalp skin organ cultures to investigate whether interferon (IFN)-γ, a key inducer of IP collapse in hair bulbs, has a similar effect on the putative bulge IP. Results: Major histocompatibility complex (MHC) class Ia, β2-microglobulin and MHC class II immunoreactivity are downregulated in the human bulge. The immunosuppressants α-melanocyte stimulating hormone, transforming growth factor-β2, macrophage migration inhibitory factor and indoleamine-2,3-dioxygenase (IDO) are upregulated in the CD200+, stem cell-rich bulge region. These CD200+ cells also co-express HLA-E. Furthermore, IFN-γ induces significant ectopic MHC class Ia expression in bulge cells of organ-cultured human scalp skin. Conclusions: These data suggest that the bulge of human anagen HFs represents a hitherto unrecognized site of relative IP in human skin. Simultaneously, we present the first evidence of IDO and HLA-E protein expression in normal human HFs. Bulge IP presumably protects the HF epithelial stem cell reservoir from autoaggressive immune attack whereas a loss of bulge IP may play a central role in the pathogenesis of cicatricial alopecias. © 2008 The Authors.

KW - Bulge

KW - HLA-E

KW - Human hair follicles

KW - Immune privilege

KW - Indoleamine-2,3- dioxygenase

KW - Macrophage migration inhibitory factor

U2 - 10.1111/j.1365-2133.2008.08818.x

DO - 10.1111/j.1365-2133.2008.08818.x

M3 - Article

VL - 159

SP - 1077

EP - 1085

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 5

ER -